Heart failure & cardiomyopathies

Circulating 3-Hydroxy Butyrate Predicts Mortality in Patients with Chronic Heart Failure with Reduced Ejection Fraction

ESC Heart FailPublished Prospective cohort study

Authors' conclusion

In patients with HFrEF, circulating 3-OHB was a strong predictor of all-cause mortality independently of NT-proBNP. Circulating FFAs were the best predictor of 3-OHB levels.

Study context

Population
Patients with chronic heart failure with reduced ejection fraction (HFrEF)
Participants
218 patients
Exposure
3-OHB above vs below median
Outcome
All-cause mortality
Follow-up
Median 7.3 (IQR 6.3-8.4) years
Methodological detailsPlasma 3-OHB measured by high-performance liquid chromatography tandem mass spectrometry, Mortality from medical records linked to the national Central Person Registry
  • Plasma 3-OHB measured by high-performance liquid chromatography tandem mass spectrometry
  • Mortality from medical records linked to the national Central Person Registry

Main finding

As reported in the abstract

median follow-up 7.3 years
Hazard ratio (95% CI)P value
3-OHB above medianvs 3-OHB low levels
2.1(1.3–3.5)
P = 0.003
3-OHBmultivariate analysis, independent of known chronic HF risk factors
1.004(1.001–1.007)
P = 0.02
NT-proBNPmultivariate analysis
1.0005(1.000–1.001)
P = 0.02
Hazard of death per 100 μmol increase in plasma 3-OHB
increased by 49%

Observational data: associations, not effects.

Further findings

Predictors of 3-OHB levels (univariate analysis)

β (95% CI)P value
FFAs238 (185–292)P < 0.0001
Age2.43 (1.14–3.72)P < 0.0001
Plasma insulin−0.28 (−0.54-(−0.02))P = 0.036
BMI−3.15 (−5.26-(−0.05))P = 0.046
Diabetes44.49 (14.84–74.14)P = 0.003
Glycosylated haemoglobin1.92 (0.24–3.59)P = 0.025
NYHA class26.86 (5.99–47.72)P = 0.012
NT-proBNP0.03 (0.01–0.04)P = 0.001
Outcomeβ (95% CI)P value
Predictors of 3-OHB levels (multivariate analysis)Only FFAs predicted 3-OHB levels216 (165–268)P > 0.001

Plasma 3-OHB levels

Large variations in 3-OHB levels between patients: median 59 μM, range 14-694 μM

Original publication

Circulating 3-Hydroxy Butyrate Predicts Mortality in Patients with Chronic Heart Failure with Reduced Ejection Fraction. ESC Heart Fail. Published 9 January 2024. doi:10.1002/ehf2.14476

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.